Growth differentiation factor 15 alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathyJordan S. F. Chan, John R. Ussher, Indiresh A Mangra-Bala et al.|Cell Reports|2024Cited by 14
Development of a succinyl CoA:3-ketoacid CoA transferase inhibitor selective for peripheral tissues that improves glycemia in obesitySeyed Amirhossein Tabatabaei Dakhili, John R. Ussher, Kunyan Yang et al.|iScience|2025Cited by 2
The antipsychotic dopamine 2 receptor antagonist diphenylbutylpiperidines improve glycemia in experimental obesity by inhibiting succinyl-CoA:3-ketoacid CoA transferaseSeyed Amirhossein Tabatabaei Dakhili, John R. Ussher, Amanda A. Greenwell et al.|Unknown|2022Cited by 1
The antipsychotic dopamine 2 receptor antagonist diphenylbutylpiperidines improve glycemia in experimental obesity by inhibiting succinyl-CoA:3-ketoacid CoA transferaseSeyed Amirhossein Tabatabaei Dakhili, John R. Ussher, Amanda A. Greenwell et al.|Unknown|2022Cited by 0
The antipsychotic dopamine 2 receptor antagonist diphenylbutylpiperidines improve glycemia in experimental obesity by inhibiting succinyl-CoA:3-ketoacid CoA transferaseSeyed Amirhossein Tabatabaei Dakhili, John R. Ussher, Amanda A. Greenwell et al.|Unknown|2022Cited by 0